3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
14
Phase 1
6
Phase NA
2
Phase 1/2
1
Status
Terminated
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Endocrine
1
CNS
1
Conditions
Carcinoma, Non-Small-Cell Lung
256
Breast Neoplasms
173
Neoplasms
169
Colorectal Neoplasms
155
Neoplasm Metastasis
126
Melanoma
120
Recurrence
118
Prostatic Neoplasms
118
Leukemia, Myeloid, Acute
117
Pancreatic Neoplasms
115
Ovarian Neoplasms
112
Multiple Myeloma
104
Lung Neoplasms
95
Stomach Neoplasms
92
Squamous Cell Carcinoma of Head and Neck
86
Triple Negative Breast Neoplasms
85
Glioblastoma
81
Lymphoma
77
Lymphoma, Non-Hodgkin
75
Lymphoma, Large B-Cell, Diffuse
65
Precursor Cell Lymphoblastic Leukemia-Lymphoma
64
Carcinoma, Renal Cell
64
Advanced Solid Tumor
59
Endometrial Neoplasms
58
Carcinoma, Hepatocellular
58
Small Cell Lung Carcinoma
55
Uterine Cervical Neoplasms
53
Sarcoma
53
Myelodysplastic Syndromes
51
Leukemia
50
Interventions
Nivolumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1/2
×
Adrenocortical Carcinoma
×
1 year
×
Clear all
NCT04187404
2026-01-30
Spencer
Enterome
Phase 1/2
Terminated
70 enrolled
20 charts